The global Cannabidiol (CBD) Nutraceuticals Market was valued at USD 9.88 billion in 2022 and is projected to reach USD 47.28 billion by 2032, with a forecasted revenue Compound Annual Growth Rate (CAGR) of 19% during the specified period. The increasing prevalence of chronic conditions like Diabetes, cancer, and arthritis is fostering the demand for CBD nutraceuticals. Research has shown that...